The genetics of chronic obstructive pulmonary disease

Respiratory Research

Volumn 2, Issue 1, 2001, Pages 20-26

  Lomas, David A ^a   Silverman, Edwin K ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Association studies; Chronic obstructive pulmonary disease; Emphysema; Genetics; Lungs

Indexed keywords

AIRWAY OBSTRUCTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FAMILY STUDY; GENE IDENTIFICATION; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; HEREDITY; HUMAN; MORBIDITY; MORTALITY; REVIEW; SMOKING;

CLONING, MOLECULAR; ENVIRONMENT; GENETIC PREDISPOSITION TO DISEASE; GENOME; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SMOKING;

EID: 0035719920     PISSN: 14659921     EISSN: None     Source Type: Journal    
DOI: 10.1186/rr34     Document Type: Review

References (70)

1. BTS guidelines for the management of chronic obstructive pulmonary disease
2. Changing smoking patterns and mortality from chronic obstructive pulmonary disease
3. Global burden of disease and injury series volume II: Global health statistics: A compendium of incidence, prevalence, and mortality estimates for over 200 conditions
4. Tobacco: The growing epidemic
5. Collagenase expression in the lungs of transgenic mice causes pulmonary emphysema
6. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice
7. Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema
8. The natural history of chronic airflow obstruction
9. Quantitative relationships between cigarette smoking and ventilatory function
10. Cumulative and reversible effects of lifetime smoking on simple tests of lung function in adults
11. Decline of lung function and development of chronic airflow limitation: A longitudinal study of non-smokers and smokers in Busselton, Western Australia
12. Relation of smoking and age to emphysema. Whole lung section study
13. Cigarette smoking and the lungs. Relation to postmortem evidence of emphysema, chronic bronchitis, and black lung pigmentation
14. The urban factor in chronic bronchitis
15. Domestic smoke pollution and chronic bronchitis in a rural community of the Hill region of Nepal
16. Twelve years spirometric changes among Paris area workers
17. Occupational dust exposure and chronic obstructive pulmonary disease. A systematic overview of the evidence
18. Cadmium fume inhalation and emphysema
19. Increased risk of obstructive pulmonary disease in tunnel workers
20. Prognostic value of nutritional status in chronic obstructive pulmonary disease
21. 1
22. Atopy, asthma, and emphysema in patients with severe alpha-1-antitrypsin deficiency
23. Latent adenoviral infection in the pathogenesis of chronic airways obstruction
24. Interaction of vitamin C on the relation between smoking and obstructive airways disease in EPIC-Norfolk
25. Childhood respiratory infection and adult chronic bronchitis in England and Wales
26. Relation of birth weight and childhood respiratory infection to adult lung function and death from chronic obstructive airways disease
27. The natural history of forced expiratory volumes. Effect of cigarette smoking and respiratory symptoms
28. Risk factors for the development of chronic obstructive pulmonary disease
29. Genetic risk factors for chronic obstructive pulmonary disease
30. 1-antitrypsin deficiency
31. 1-antitrypsin accumulation in the liver
32. 1-antitrypsin and liver cirrhosis
33. 1-antitrypsin deficiency, PiZ
34. Decline in FEV1 related to smoking status in individuals with severe alpha1-antitrypsin deficiency
35. 1-antitrypsin, and immunoglobulin E after adjustment for the effect of the Pi locus
36. Collaborative study to assess risk of lung disease in Pi MZ phenotype subjects
37. 1-antitrypsin Pi-types in 965 COPD patients
38. 1-antitrypsin Pi types in COPD patients
39. Longitudinal lung function study in heterozygous PiMZ phenotype subjects
40. Genetic and environmental determinants of chronic obstructive pulmonary disease
41. Familial prevalence of chronic obstructive pulmonary disease in a matched pair study
42. Major genetic mechanisms in pulmonary function
43. Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease
44. Case-control association studies for the genetics of complex respiratory diseases
45. Chronic obstructive pulmonary disease: A challenge in genetic epidemiology
46. 1-antitrypsin gene in chronic lung disease
47. 1-antitrypsin gene region in patients with chronic obstructive pulmonary disease
48. 1-antitrypsin enhancer results in an interleukin-6 deficient acute phase response due to loss of cooperativivity between transcription factors
49. Mutation in the 3′ region of the α-1-antitrypsin gene and chronic obstructive pulmonary disease
50. 1-antichymotrypsin mutations in patients with obstructive pulmonary disease
51. 1-proteinase inhibitor gene between asthmatic and non-asthmatic black and white South Africans
52. 1-antitrypsin deficiency alleles and the Taq-1 G→A allele in cystic fibrosis lung disease
53. 1-antitrypsin genotypes and the acute-phase response to open heart surgery
54. 1-antichymotrypsin deficiency in a heterozygote with liver and lung disease
55. 1-antichymotrypsin allele associated with familial obstructive lung disease
56. 1-antichymotrypsin indicates two stage insertion of the reactive loop; Implications for inhibitory function and conformational disease
57. 1-antichymotrypsin mutations in patients with chronic obstructive pulmonary disease
58. Expression of the secretory leukoprotease inhibitor gene in epithelial cells
59. SKALP/elafin gene polymorphisms are not associated with pustular forms of psoriasis
60. Effects of a polymorphism in the human tumor necrosis factor-α promoter on transcriptional activation
61. Tumor necrosis factor-α gene polymorphism in chronic bronchitis
62. Tumor necrosis factor gene complex in COPD and disseminated bronchiectasis
63. Tumour necrosis factor-α gene promoter polymorphism in chronic obstructive pulmonary disease
64. Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema
65. Association of genetic polymorphisms with rate of decline of lung function
66. Genetic susceptibility to chronic obstructive pulmonary disease in Koreans: Combined analysis of polymorphic genotypes for microsomal epoxide hydrolase and glutathione S-transferase M1 and T1
67. Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema
68. Glutathione S-transferase P1 (GSTP1) polymorphism in patients with chronic obstructive pulmonary disease
69. A common familial component in lung cancer and chronic obstructive pulmonary disease
70. Airways obstruction and the risk for lung cancer